Several cell properties enabling discrimination of LSCs from HSCs within AML bone marrows were identified, including expression of CLEC12A (CLL-1), CD123, TIM-3, CD34 and CD45, scatter properties and activity of aldehyde dehydrogenases [12,13,14,15,16]. Here, CD34 is linked to acute myeloid leukemia.